Table 1.
Characteristic | Nasopharyngeal carcinoma patients (N=178) % |
---|---|
Sex |
|
Female |
45 (25.3) |
Male |
133 (74.7) |
Age (years) |
|
Median (range) |
46 (19–75) |
≤46 |
99 (55.6) |
≤46 |
79 (44.4) |
Follow-up time (months) |
|
Median (range) |
56 (3–89) |
Tumor size |
|
T1+T2 |
58 (32.6) |
T3+T4 |
120 (67.4) |
Lymphoid nodal states |
|
N0-1 |
92 (51.7) |
N2-3 |
86 (48.3) |
Clinical stage |
|
I+II |
33 (18.5) |
III+IV |
145 (81.5) |
Local-regional relapse |
|
Yes |
23 (12.9) |
No |
155 (87.1) |
Metastasis |
|
Yes |
33 (18.5) |
No |
145 (81.5) |
WHO histological classification |
|
NKUC |
170 (95.5) |
NKDC |
8 (4.5) |
OS rate (%) |
|
5-year | 53.9 |
Abbreviations NPC nasopharyngeal carcinoma, WHO World Health Organization, NKUC non-keratinizing undifferentiated carcinoma, NKDC non-keratinizing differentiated carcinoma, OS overall survival.